#1 2020-09-13 20:39:40

JonelleMen
Member
From: France, Chatou
Registered: 2020-09-12
Posts: 1

“That will send tremors throughout the industry,” Neal adds

Blog                                                                                                                                                                                          .

The Future of Clinical Research Technology: Site Selection
Complion  08/24/2020  Clinical Research Trends

  Research Sites             Inefficient and ineffective.
That’s how John Neal, CEO of PCRS Network, sums up his frank assessment of the  current state  of the clinical research site selection process.
In the third post of this  four-part series , we explore the evolution of clinical research and its impact on the site selection process based on insights presented by Neal.
Something  on the order of 50% of all sites that are initiated across all studies don’t meet their original enrollment expectations,” Neal observes.
His re search  reveals that up to 11% of sites never enroll a single subject.
The problem is in  the process , and that process will change, Neal predicts.
One aspect of that change will be that the  selection  of sites will begin with the identification of patients.
“Starting there and working backward is a huge  paradigm shift ,” he notes.
“That change will drive increases in  efficiency , and will minimize the number of nonperforming or underperforming sites.
“That will send tremors  throughout  the industry,” Neal adds.
“Right now we have a lot of sites that are  fighting  for attention, fighting to get the next study.
As the site selection process improves, some sites are going to lose that fight.
As an industry, as we get better at identifying and selecting sites, instead of initiating 100 sites, 50 of which will underperform, you’re going to see maybe 30 sites that are initiated, all of which will meet performance expectations.” As fewer sites are needed, some study procedures will be performed outside of the traditional site venue and site structure.
Certain study visits may occur at the subject’s primary care physician’s office, or at a specialist’s office, Neal predicts.
“That has major implications and ramifications for staffing and for site selection,” Neal says.
“When proximity to the initiated site’s location no longer limits the selection of study subjects, you now open up the opportunity for a site to have volunteers enrolled that may be on the other side of the continent.” Out goes inefficiency, in comes the future.
Are you ready.
In our last post of the series, Neal takes a look at single dose studies and the opportunity for collaboration between multiple sponsors.
Learn more about the Complion eRegulatory solution or schedule a demonstration to see how Complion can streamline your document management.
ICYMI (In case you missed it).
The first post in this four-part series: The Future of Clinical Research Technology: Introduction.
The second post in this four-part series: The Future of Clinical Research Technology: Data Collection.
Share this:.
Twitter.
Facebook.
LinkedIn.
The Future of Clinical Research Technology: Site Selection.

Offline

Basketball Star Slot

Board footer

Powered by FluxBB